Previous Article | Next Article ![]()
Molecular and Cellular Biology, January 2005, p. 685-698, Vol. 25, No. 2
0270-7306/05/$08.00+0 doi:10.1128/MCB.25.2.685-698.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Céline Plachez,2
Kenneth G. Butz,1
Guanhu Yang,3
Cindy J. Bachurski,3
Stephen L. Kinsman,4
E. David Litwack,2
Linda J. Richards,2 and
Richard M. Gronostajski1*
Department of Biochemistry and the Program in Neuroscience, State University of New York at Buffalo, Buffalo, New York,1 Division of Pulmonary Biology, Cincinnati Children's Research Foundation, Cincinnati, Ohio,3 Department of Anatomy and Neurobiology and Program in Neuroscience,2 Department of Pediatrics, University of Maryland, Baltimore, School of Medicine, Baltimore, Maryland4
Received 25 September 2004/ Accepted 10 October 2004
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
We showed previously that disruption of Nfia causes late gestation neuroanatomical defects, including agenesis of the corpus callosum, size reductions in other forebrain commissures, and loss of specific midline glial populations (11, 56). In contrast, disruption of Nfic results in early postnatal defects in tooth formation, including the loss of molar roots and aberrant incisor development (61). In a previous study, insertion of a lacZ reporter gene into the Nfib locus resulted in defects in lung maturation but no apparent defects in brain development (22). Here we report the replacement of the essential exon 2 of the Nfib gene with a lacZ reporter gene and show that mice homozygous for our replacement mutation have major neuroanatomical defects similar to, but more severe than, those of Nfia/ mice. These defects include callosal agenesis, aberrant hippocampus and pons formation, and loss of specific midline glial populations. In addition, as was seen in the previously described Nfib insertion mutant, these Nfib-deficient animals show defects in lung development and die at birth with immature lungs. The loss of one copy of Nfib results in callosal agenesis in some animals and reduced lung maturation in all animals, demonstrating haploinsufficiency at the Nfib locus. Together, these defects indicate that Nfia and Nfib may function cooperatively during mouse forebrain development and that Nfib alone is essential for late gestational lung maturation and hippocampus and pons development.
| MATERIALS AND METHODS |
|---|
|
|
|---|
3 kb of intron 2. The NLS-ß-Gal-pA and Neo cassettes replace 700 bp of Nfib, including all but 9 bp of exon 2. A diphtheria toxin A chain-expressing negative selection cassette (PGK-DTA-bGHpA) was assembled and cloned downstream of the 3' homologous region in the opposite transcriptional orientation (67). E14-1 mouse embryonic stem (ES) cells (5 x 106) were electroporated with 5 µg of gel-purified 15.2-kb XhoI targeting vector fragment and then selected in 0.2-mg/ml G418 (GIBCO/BRL) for 6 days. Colonies were picked and expanded twice in 96-well plates. Two plates were frozen, and two were used for DNA isolation and Southern blot analyses. Correctly targeted ES cells were injected into C57BL/6 blastocysts, and stable transmission of the targeted allele was assessed by PCR genotyping of the progeny of founder male chimeras. The targeted (knockout [KO]) allele was crossed into Black Swiss (Taconic), C57BL/6 (Taconic and Jackson Laboratories), and FVB/N (Jackson Laboratories) strains for analysis. Mice derived from two independent targeted ES cell clones were analyzed and had indistinguishable phenotypes. Since some 129 strains of mice have a recessive callosal agenesis phenotype (35, 36) and since the ES cells used were derived from 129S6 mice, all brain sections were prepared from mice backcrossed into the Black Swiss (one generation) or C57BL/6 (more than five generations) strain to avoid the as yet uncharacterized 129 recessive acallosal-susceptibility locus. The lung morphology phenotypes of Nfib mutant animals of the Black Swiss, C57BL/6, and FVB/N strains were indistinguishable. Each figure legend contains the strain used in the figure.
PCR genotyping. Postnatal day 10 (P10) to P14 0.5-cm tail tip biopsy samples were shaken at 55°C overnight in 0.5 ml of tail lysis buffer (100 mM Tris-Cl [pH 8.5], 5 mM EDTA, 200 mM NaCl, 0.2% sodium dodecyl sulfate) including 0.1 mg of proteinase K/ml. One microliter of the lysate diluted 1:10 in H2O was analyzed by multiplex PCR (0.5 U of Platinum Taq DNA polymerase [Invitrogen], 1.5 mM MgCl2, 0.2 mM [each] deoxynucleoside triphosphate, 1x Rediload [Research Genetics], 1x PCR buffer [Invitrogen; 10 mM Tris-Cl {pH 8.3}, 50 mM KCl, 0.02 mg of bovine serum albumin/ml], five primers at 0.2 µM each). Primers were Nfib specific (a and b), lacZ specific (c), or mouse Y chromosome specific (SRY-1 and -2); sequences are as follows: a, 5'-GCTGAGTTGGGAGATTGTGTC-3'; b, 5'-TTCTGCTTGATTTCGGGCTTC-3'; c, 5'-CATCGTAACCGTGCATCTGCC-3'; SRY-1, 5'-AACAACTGGGCTTTGCACATTG-3'; SRY-2, 5'-GTTTATCAGGGTTTCTCTCTAGC-3'). PCR products were resolved on 2.0% agarose gels and visualized with ethidium bromide.
PCR and QPCR transcript analysis. Total RNA was isolated with TRIzol reagent (Invitrogen), and cDNA was generated from 2 to 5 µg of RNA with Superscript II reverse transcriptase (Invitrogen) and random primers as recommended by the manufacturer. Nfib transcripts were analyzed by PCR with an exon 1-based sense primer (5'-GATCGGCCTCACGGGCCGATGATGTATTCTCCCATCTG-3') and an exon 4-based antisense primer (5'-CTCTGATACATTGAAGACTCCG-3'), and products were resolved on a 2.5% agarose gel. Transcript levels of all genes shown were quantified by quantitative PCR (QPCR) with a Bio-Rad iCycler real-time PCR machine and gene-specific primers that span multiple exons as described previously (61). Primer sequences for the genes quantified are available upon request.
Tissue preparation and lacZ detection. Embryos were harvested at various times after detection of a coital plug. For total lung DNA analysis, either the dissected left lobe (embryonic day 18.5 [E18.5]) or the whole lung (E15.5) was harvested into 1 ml of 2 M NaCl-2 mM EDTA in phosphate-buffered saline (PBS) and sonicated on ice, and DNA content was assayed fluorimetrically as described previously (32) with a 96-well plate fluorimeter and purified calf thymus DNA as a standard. Whole thoraces were immersed in cold 4% paraformaldehyde (PFA) overnight, washed in PBS, dehydrated in ethanol, embedded in paraffin, and transversely sectioned at 5 µm for hematoxylin and eosin (H&E) staining and immunohistochemistry.
ß-Gal staining was performed on cryostat sections of frozen fixed tissues. Lungs were fixed in PBS containing 0.2% glutaraldehyde, 5 mM EGTA (pH 7.3), and 0.1 M MgCl2 for 3 h on ice and rinsed three times for 15 min with cold PBS. Fixed tissues were cryoprotected overnight in cold 30% sucrose in 1x PBS and then embedded in OCT embedding medium and snap-frozen on dry ice. Cryostat sections of frozen tissue (10 µm) were loaded onto polylysine-coated slides and allowed to dry at room temperature for 2 h and incubated in ß-Gal solution (5 mM potassium ferricyanide, 5 mM potassium ferrocyanide, 1 mg of X-Gal [5-bromo-4-chloro-3-indolyl-ß-D-galactopyranoside]) in buffer (100 mM sodium phosphate [pH 7.3], 2 mM MgCl2, 0.01% sodium deoxycholate, 0.02% NP-40) at room temperature for 6 h. Stained sections were washed three times in PBS and then postfixed in distilled water containing 2% glutaraldehyde, 2% PFA, and 0.1 M sodium cacodylate for 1 h at 4°C. The slides were rinsed in three changes of cold PBS for 10 min each, cleared in distilled water for 5 min, and then counterstained with 0.1% nuclear fast red in 5% aluminum sulfate for 2 min, washed in running water, dehydrated, and topped with coverslips for analysis.
For whole-mount staining fixed lungs were washed and immediately incubated in ß-Gal solution at room temperature overnight without cryoprotection. Stained lung lobes were washed three times with PBS and postfixed as described above, and washed left lobes were photographed through a dissecting microscope.
Brain sectioning and staining. Brains were perfused with 4% PFA, fixed overnight in 4% PFA, and stored in PBS until use. Brains were blocked in 3% agar and cut at 40 to 50 µm on a vibratome (Leica, Deerfield, Ill.). The sections were counterstained with 2% Mayer's hematoxylin (Sigma Chemical Co.) for 6 min, or alternatively with 1% thionin, rinsed, dehydrated, and mounted for analysis.
Immunohistochemistry. All procedures were performed at room temperature. Brain sections were washed three times in PBS and blocked in a solution of 2% (vol/vol) serum and 0.2% (vol/vol) Triton X-100 (Sigma) in PBS for 2 h. Normal goat serum (S-1000; Vector Laboratories, Burlingame, Calif.) or normal donkey serum (017-000-121; Jackson ImmunoResearch Laboratories, West Grove, Pa.) was used as the blocking agent. The sections were incubated with the primary antibody, rabbit anti-glial fibrillary acidic protein (GFAP; 1:30,000; Z0334; Dako, Glostrup, Denmark) or rat anti-L1 (1:5,000; MAB5272; Chemicon, Temecula, Calif.), overnight. Sections were then washed three times in PBS and incubated with the biotinylated secondary antibody (biotinylated goat anti-rabbit secondary antibody [1:500; Vector Laboratories] or biotinylated donkey anti-rat secondary antibody [1:500; Jackson ImmunoResearch Laboratories]) for 2 h. After three washes in PBS, sections were incubated in avidin-biotin solution (1:500; Vector Laboratories) for 1 h, followed by three washes in PBS. Sections were then immersed in a nickel-3,3'-diaminobenzidine (DAB; D-5905; Sigma)-chromogen solution (2.5% nickel sulfate and 0.02% DAB in 0.175 M sodium acetate) activated with 0.01% (vol/vol) H2O2 until a dark purple-black precipitate formed. Sections were washed in PBS, mounted, and placed on coverslips in DPX mounting medium (Electron Microscopy Services). Labeling was analyzed with an upright light microscope (Leica). Images were made with a PowerPhase digital camera (PhaseOne, Copenhagen, Denmark) directly into Adobe Photoshop software.
Immunohistochemistry for
smooth muscle actin (
SMA) was performed essentially as described previously (41). The smooth muscle differentiation marker
SMA was detected with mouse monoclonal anti-
SMA 1A4 (1:20,000; Sigma). Staining was performed with the Mouse on Mouse kit (Vector Laboratories). Biotinylated secondary antibodies were used with a nickel-enhanced DAB protocol essentially as described for the brain except that slides were counterstained with nuclear fast red.
| RESULTS |
|---|
|
|
|---|
|
Lung maturation defects in Nfib-deficient mice. A previous study showed that mice with an insertion of a lacZ translational fusion gene into the same EcoRI site in exon 2 of Nfib targeted here exhibited defects in lung maturation (22). We therefore examined lung development in our Nfib-null mice. Mouse lung maturation occurs relatively late in gestation, with final prenatal maturation (sacculation) occurring from E16.5 to P3 (10). Histological examination of lungs in E17.5 Nfib-deficient mice showed that lungs from Nfib/ mice were severely defective in maturation, while those from Nfib/+ animals had a clear developmental delay in maturation. WT lungs at E17.5 were well sacculated (Fig. 2A), while lungs from Nfib/+ mice had smaller saccules (Fig. 2B) and lungs of Nfib/ mice completely lacked saccules (Fig. 2C). The morphology of the E17.5 Nfib/ lungs resembled that of less-mature WT E15.5 lungs (Fig. 2, compare panels C and D). To assess the approximate time in development at which maturation was arrested, we examined the morphology of E15.5 WT, Nfib/+, and Nfib/ lungs (Fig. 2D to F, respectively). Unlike the case at E17.5, at E15.5 the WT and mutant lungs had similar morphologies with dense mesenchyme and no saccules. In addition, levels of smooth muscle actin expression around the bronchioles (Fig. 2D to F) and vessels (Fig. 2D and F) in WT and mutant mice were similar. These data indicate that lung development in Nfib/ mice appears arrested between E15.5 and E16.5 at the late-pseudoglandular-to-early-canalicular stage of development and that Nfib/+ mice have a less severe phenotype of delayed lung maturation.
|
60% of the predicted number of Nfib/+ animals survived (34 of 58 predicted Nfib/+ animals). The lethality appears to be perinatal since the genotypes of E17.5 to E18.5 embryos were present at nearly the expected Mendelian frequency of 1:2:1 (66 Nfib+/+ mice, 115 Nfib/+ mice, and 70 Nfib/ mice; 31 litters). Compared to Nfib+/+ animals in the same litters, only
55% of Nfib/+ animals in the C57BL/6 strain survived to genotyping, suggesting that the delay in lung maturation in Nfib/+ animals reduces early postnatal survival in this strain (Table 2; 70 Nfib/+ mice survived to day 14 versus 124 Nfib+/+ mice; 26 litters). Surprisingly, little or no loss of heterozygotes was seen during backcrossing to the FVB/N strain, indicating that this reduction in heterozygote survival is strain specific (Table 2; 83 Nfib/+ mice versus 75 Nfib+/+ mice survived to day 14; 17 litters). Histological evaluation of heterozygote E18.5 lungs showed that delays in sacculation were indistinguishable among the strains. Whether this difference in survival of Nfib-deficient heterozygotes among strains is dependent on modifier genes and/or maternal rearing differences remains to be determined. These data strongly support a model for haploinsufficiency at the Nfib locus.
|
|
|
|
2-fold increase in Fgf-10 levels and no change in Fgf-7 levels in E18.5 Nfib/ lungs relative to Nfib+/+ lungs, there was an
11-fold increase in Midkine expression in the mutant lungs (Table 4). Since increased Midkine levels have been associated with the decreased lung maturation seen in glucocorticoid receptor-deficient mice (28) and with lung vascular remodeling after hypoxia (48), it will be important to assess Midkine's role in the apparent increase in mesenchymal cell density in Nfib/ lungs.
|
Nfib::lacZ expression during lung development. Lung development requires many reciprocal epithelial-mesenchymal inductions (see references 25 and 54 for reviews). While our previous in situ data showed that Nfib is highly expressed in the developing lung (6), the cellular expression pattern was not determined. To identify the specific cell compartments where Nfib is expressed during lung development, we stained lungs of mice heterozygous for the Nfib::lacZ allele for ß-Gal activity. Nfib::lacZ was uniformly expressed at high levels throughout the mesenchyme at E14.5, whereas weaker expression was detected in a few scattered epithelial cells at this time (Fig. 4A). Nfib::lacZ was expressed at similar levels in most epithelial and mesenchymal cells at E16.5, with increased expression in smooth muscle (Fig. 4B). At E18.5, Nfib::lacZ was expressed in a subset of both proximal and distal epithelial cells, while mesenchymal expression was decreased but still present in the smooth muscle (Fig. 4C and D). LacZ staining was not detected in WT E18.5 lung (Fig. 4E). In adult lung Nfib::lacZ was expressed primarily in the bronchiolar epithelium and type II cells (Fig. 4F). Preliminary immunohistochemistry with Nfib-specific antibodies supports this pattern for endogenous Nfib in WT mice (C. Bachurski, unpublished data). These data indicate that Nfib could play essential roles in either the lung mesenchyme or epithelium during late prenatal lung maturation.
|
|
Midline glial populations are important for the formation of the corpus callosum, as they secrete guidance factors, such as Slit2, that guide callosal axons both before and after they cross the midline (58, 59). Figure 6 shows an immunohistochemical analysis of GFAP expression. Three midline glial populations are evident in WT animals: the glial wedge (GW), glia within the indusium griseum (IGG), and the midline zipper glia (MZG; Fig. 6D) (57). Nfib/ mice showed a reduction in GFAP expression at the midline, which likely reflects a loss or reduction in these glial populations. This phenotype is similar to that observed in Nfia/ mice (56). Nfib/ mice display a complete absence of GFAP labeling in the regions of both the IGG and the MZG (Fig. 6F and L). Furthermore, although a few glial cells were present, the GW was greatly reduced in the Nfib/ animals (Fig. 6F and L). Since there are NFI binding sites in the GFAP gene promoter, these results, together with our results for Nfia/ mice (56), suggest that NFI genes may regulate both GFAP expression and glial development. Further evidence for such regulation is that Nfib/+ mice on a C57BL/6 background display lower levels of expression of GFAP than their Nfib+/+ littermates (compare Fig. 6K and J). Although all three midline glial populations were present in Nfib/+animals on both the Black Swiss and C57BL/6 background, the IGG appeared disorganized on the Black Swiss background, probably due to the formation of Probst bundles at the midline (Fig. 6E).
|
5-fold in Nfib/ brains relative to WT, this decrease is less than the
10-fold decrease seen in Nfia/ brains (Table 5). While examining the expression of genes proposed to influence forebrain development in Nfia KO mice, we noted that Tbr2 transcript levels were increased 1.9-fold in Nfia/ brains relative to Nfia+/+ brains (Table 5). However, Nfib/ brains had no higher levels of Tbr2 transcripts than did Nfib+/+ brains (Table 5). Thus, while the neuroanatomical defects in the Nfib/ brains appear more severe than those of Nfia/ brains, the changes in GFAP and Tbr2 expression in Nfib/ brains are less than those observed in Nfia/ animals. In addition, there were no apparent changes in the levels of transcripts for some other genes that have been proposed to play a role in callosum formation and forebrain development, including Slit2, Robo1 to -3, DCC, Netrin, and others (Table 5). Thus the reduction in GFAP transcripts is the only consistent change in gene expression so far detected in Nfib/ brains and is likely due at least in part to the observed loss of GFAP expression from specific midline glial cells.
|
|
|
5.1, 3.3, and 2.8-fold increases in Nfia, Nfic, and Nfix expression, respectively, in Nfib/ lungs relative to WT lungs (Table 6). Thus, of the three NFI genes remaining in Nfib/ mice, the Nfia gene has the largest increase in expression in lung. In E18.5 whole brain, there was a 2.2-fold increase in Nfia expression but no significant change in Nfic or Nfix expression (Table 6). These data indicate that there were greater changes in the expression of the remaining Nfi genes in the lungs of Nfib-deficient animals than in the brains of these animals and that Nfia exhibited the greatest changes in both tissues. The significance of these changes and their relationship to the phenotypes seen in the tissues are being examined.
|
| DISCUSSION |
|---|
|
|
|---|
Lung maturation defects in Nfib/ animals. Lung maturation defects that are morphologically similar to those seen in our Nfib/ animals were described previously for an insertion mutation in the Nfib locus (22). While that study described the defect as lung hypoplasia, our analysis shows that there is an apparent increase in the amount of DNA in Nfib/ lungs (Table 3), suggesting aberrant cell proliferation and/or apoptosis during lung maturation. Increased PCNA expression at E18.5 in Nfib/ versus WT lungs is also consistent with increased cell proliferation (Table 4). Prenatal lung maturation proceeds through a series of morphologically and biochemically defined stages (10) from budding (approximately E9.5), initial branching morphogenesis and expansion (pseudoglandular, approximately E9.5 to E16.5), continued branching of the distal epithelium and mesenchyme (canalicular; approximately E16.5 to E17.5), and formation of terminal saccules with terminal differentiation of type I and type II epithelial cells (sacculation; approximately E17.5 to P5). Final maturation of the terminal sacs into alveolar ducts and sacs (alveolization) occurs postnatally from approximately P5 to P30 (47, 65). The reduction of specific epithelial markers seen here (Table 4), together with the lack of saccule formation, indicates that the lungs in Nfib/ mice are arrested at the late-pseudoglandular or early-canalicular stage of maturation. Since the morbidity and mortality of premature infants are strongly associated with a failure of lung maturation (45), these mice may provide a useful model to investigate the later stages of prenatal lung maturation.
Failure of late fetal lung maturation has also been seen in mice containing targeted disruptions of the genes encoding glucocorticoid receptor (9), transforming growth factor ß3 (55), endothelial nitric oxide synthase (24), and Sp3 (5) and other genes (66, 68, 69). The pathways linking this diverse set of molecules to the developmental events essential for lung maturation have not yet been determined. Given the possible increase in cell number seen in the Nfib/ lungs (Table 3), it is of interest that the combined loss of p21CIP and p57KIP2, two Cdk inhibitors that mediate cell cycle arrest, results in a maturation arrest that appears morphologically similar to that seen with loss of Nfib (69). Thus it is possible that Nfib is involved in either mesenchymal or epithelial cell exit from the cell cycle and that this cell cycle arrest is essential for normal maturation of the lung. Consistent with this model are the observations that overexpression of NFIB and other NFI proteins can suppress the oncogenic transformation of chicken embryo fibroblasts mediated by a number of nuclear oncogenes (52) and that rearrangement or altered expression or both of NFIB have been associated with the overgrowth syndromes of pleomorphic adenoma (17) and polycythemia vera (29). To test this model, it will be useful in future studies to determine whether the apparent increase in cell number in the Nfib/ lungs is due to changes in cell proliferation, apoptosis, or both.
Since Nfib/ mice have defects in both lung maturation and commissural tract formation (Fig. 2 to 8), it is noteworthy that loss of the known axon guidance receptor gene Robo1 also causes perinatal lethality attributed to a failure of lung maturation (66). Robo1 is a mouse ortholog of Roundabout, which is essential for normal midline axonal crossing in Drosophila (26). The Robo gene family encodes receptors with homology to the neural CAM family of cell surface adhesion molecules and appears to regulate axon guidance in both Drosophila and mice (49). This gene family has been implicated in regulating axon guidance in mice and humans (27, 37, 63), but its role in lung development is unknown (1). The expression patterns for Robo and Slit family members during lung maturation are consistent with a role for Robo signaling in epithelium-mesenchyme interactions (19). Although we observed no decrease in overall Robo1 expression in Nfib/ brains (Table 4), analysis of the expression patterns of Robo1 and other signaling molecules by in situ hybridization in Nfib/ animals might reveal regional changes in expression related to the observed phenotypes in brain and lung.
It will be important to determine the specific gene expression changes in Nfib/ lungs that affect maturation. However, given the failure of lung maturation in the Nfib/ mice, it will be essential to distinguish between changes that directly affect the maturation process and those that simply reflect the immature state of the Nfib/ lungs. For example, while we've seen decreases in the expression of a number of type II and type I epithelial markers in E18.5 Nfib/ lungs (Table 4), it is possible these changes merely reflect lack of maturity of the Nfib/ versus Nfib+/+ lungs. Since the expression levels of several of these genes normally increase during lung maturation, it is not surprising that their expression levels are reduced in the less mature Nfib/ lungs. Thus it will be important to determine the earliest time in development at which differences in gene expression between Nfib/ and Nfib+/+ lungs occur and which of the genes affected at this time are essential for maturation.
One known target for NFI genes in the developing lung epithelium is SP-C. Previous studies showed that the SP-C gene promoter is activated by NFI proteins, including NFI-B2, and that a transgene-encoded dominant repressor (NFI-engrailed) inhibits the expression of SP-C in mouse lung (2, 3). Thus SP-C is a good candidate for a direct target of Nfib in the developing lung. However, SP-C is highly expressed only late in lung maturation and SP-C mutant mice do not exhibit a failure in lung maturation (18). Given the expression pattern of the Nfib::lacZ allele (Fig. 4), it is possible that Nfib regulates both mesenchymal target genes that are essential for the maturation process early in lung development and also epithelial genes that are expressed later in lung development and that are important for physiological functioning of the lung. An important future goal is to distinguish between these two potential classes of Nfib target genes.
Neurological defects in Nfib/ animals. While the callosal agenesis (Fig. 5 and 6) and loss of midline GFAP staining (Fig. 6) seen in Nfib/ animals is reminiscent of the phenotype seen previously in Nfia/ mice (11, 56), there are clear morphological differences between the two mutants. For example, Nfib/ animals usually lack large Probst bundles, regions of axonal overlap and swirling near the midline that are often present in Nfia/ animals (56). Such differences imply that, while both genes are essential for callosal formation, they may have both shared and distinct functions in this developmental process. Both Nfia and Nfib are expressed in the cortex (6, 56) (data not shown), but the lack of markers specific for callosally projecting neurons makes it difficult to assess the significance of this cortical expression. The similar losses of midline glial populations in Nfib/ mice (Fig. 6) and Nfia/ mice (56) suggest that both genes may cooperate in the growth and differentiation of these midline glial cells. Given the relatively restricted set of glial cells affected by loss of either Nfia or Nfib, it will be of interest to determine whether simultaneous loss of both Nfi genes produces a more severe phenotype in glial cell development.
While both Nfia- and Nfib-deficient mice exhibit agenesis of the corpus callosum, the Nfib-deficient mice have additional neurological defects not reported for Nfia-deficient animals, including severe defects in hippocampus (Fig. 7) and pons (Fig. 8) formation. Nfib had been shown previously to be expressed in both the hippocampus and the pons (6, 16), and thus it is possible that the defects in these regions are due to cell-autonomous defects in cells that normally express Nfib. Nfib is one of a small class of genes known to affect hippocampus development, a class which includes the genes Lhx-5 (70), Beta2/NeuroD (34), Lef-1 (15), CXCR4 (38), LRP6 (71), and Emx-2 (46, 51) and the Reelin-Disabled-1-beta(1)-class integrin pathway (14). The mechanisms by which these genes affect the molecular pathways and cellular processes essential for hippocampal development are beginning to be understood. LRP6-deficient mice have generalized defects in the Wnt/beta catenin signaling pathway because of the crucial function of LRP6 as a Wnt signaling coreceptor (71). These mice have severe defects in the dentate gyrus due to the decreased production of dentate granule cells. They also have abnormalities of the radial glial scaffolding in the forming dentate gyrus. By examining the hippocampal primordium at early stages, the authors showed a reduction in the number of dentate granule cell progenitors in the dentate ventricular zone prior to the emigration of the earliest granule neurons and precursors to form the dentate anlage. It is possible that loss of Nfib-regulated gene transcription may lead to a similar alteration of the hippocampal primordium, with resultant severe hypoplasia of the dentate gyrus. A more detailed analysis of early hippocampus development in the Nfib/ mice should allow us to test this model for Nfib function in the dentate gyrus.
The molecular mechanisms leading to the loss of the basilar pons in Nfib/ mice are unknown. It may be that Nfib regulates one or more signaling molecules, such as DCC or Rig-1/Robo3, that control the migration of pontine neurons to the midline (39). Alternatively, Nfib may interact with other transcription factors that regulate pontine formation (4, 13, 33). Distinguishing between these and other possibilities awaits characterization of the fate of pontine neurons in Nfib/ mice. Since analysis of whole-brain RNA has failed to find changes in the expression of some molecules known to influence axon guidance and cell migration (Table 5), determining whether there are common Nfib target genes that mediate the defects in callosal formation, hippocampal development, and pons formation will require a detailed analysis of Nfib target genes in each of these regions of the brain.
Given the severity of the neurological phenotypes seen in the Nfib/ animals, it is perhaps surprising that a previous study of an insertion of a lacZ translational fusion gene into the Nfib locus found no neurological defects (22). This is despite the finding that the lung maturation defects seen in our Nfib KO animals appear morphologically similar to those seen in animals with the Nfib insertion mutation. There are several possible explanations for such differences. (i) With both our Nfia/ and Nfic/ mice we showed that deletion of exon 2 results in aberrant splicing from the first to the third exons of the genes (11, 61). We show a similar aberrant transcript from our disrupted Nfib locus (Fig. 1C). These aberrant transcripts do not encode functional proteins as they are missing DNA binding and dimerization domains and as the exons are out of frame, yielding short missense peptides. It is possible that aberrant splicing into the still-present second exon of the insertion mutant gene could generate a hypomorphic, but not null, allele in these animals. In our Nfib mutant allele the second exon is deleted, precluding this possibility. (ii) We showed previously that Nfib has an alternative first exon, expressed specifically in the brain (21, 42). Splicing from this brain-specific exon into the still present second exon of the insertion mutant gene may be why no brain phenotype for the insertion mutant was seen. Also, the report for the insertion mutant failed to show any ß-Gal activity from the targeted allele or to demonstrate loss of Nfib expression, making it difficult to compare to the present study. While further studies are needed to resolve these differences, it is clear that our Nfib/mice have severe lung and brain phenotypes, making them an important tool with which to study Nfib function.
NFI gene family in mouse development. Three of the four mouse NFI genes have now been disrupted, and each mutant has unique defects in development. Disruption of Nfia results in callosal agenesis, perinatal lethality, hydrocephalus, reduction in the hippocampal commissure, and loss of specific midline glial populations (11, 56). Some of these defects are also present in the Nfib/ mice described here. In contrast, disruption of the Nfic gene results in postnatal defects in tooth formation, with no observable defects in neuroanatomy and no lethality if the diet is composed of soft food (61). Since the Nfib/ mice do not survive postnatally, it is not possible to tell if they have tooth defects similar to those seen in Nfic/ mice. Since the four NFI genes encode proteins with highly homologous DNA-binding domains with similar DNA-binding specificities (40), it is possible that there are common downstream targets for all four NFI genes. It is unclear whether the diverse defects seen upon loss of the individual NFI genes are due to differences in the expression patterns of the four genes, differences in downstream target specificity, differences in gene activation or repression by specific NFI isoforms, or other factors. One feature that is common in the mutants is that the defects are seen relatively late in fetal or postnatal development. In Nfia/ and Nfib/ mice the first morphological indication of differences is at E14 to E15, while for Nfic/ mice the first changes are seen at approximately P10. Thus at least three of the four NFI genes are essential for relatively late developmental processes in the mouse. Since the four NFI genes are expressed in an overlapping pattern during development (6) and since changes in NFI transcript levels are first detected at the four-cell stage in embryogenesis (23), it will be of interest to determine whether multiple NFI genes cooperate at earlier stages of mouse development.
It is difficult to connect the diverse defects seen in the Nfib/ mice, callosal agenesis, aberrant gliogenesis, hippocampus and pons development, and failure of lung maturation, into a simple model of Nfib function. It will be necessary to determine the earliest stages at which gene expression changes occur in the affected tissues in order to determine whether common or unique Nfib target genes are affected in each organ. Since different NFI proteins have been found to either activate or repress expression from the same promoter depending on the cellular context (7, 8; reviewed in references 21 and 42), it will be important to analyze mice with mutations in multiple NFI genes to determine whether they cooperate or antagonize each other at earlier developmental stages. The future identification of direct downstream targets of Nfib, together with analysis of the effects of the combined loss of Nfib together with other genes known to affect brain and lung formation, should allow us to determine the molecular mechanisms through which Nfib functions in lung and brain development.
| ACKNOWLEDGMENTS |
|---|
This work was supported in part by Public Health Service grants HD34901 from the National Institute of Child Health and Development and DK58401 and DK48796 from the National Institute of Diabetes and Digestive and Kidney Diseases to R.M.G. and HL60907 from the National Heart, Lung and Blood Institute to C.J.B.
| FOOTNOTES |
|---|
Present address: Buffalo, NY 14215. ![]()
| REFERENCES |
|---|
|
|
|---|
2. Bachurski, C. J., S. E. Kelly, S. W. Glasser, and T. A. Currier. 1997. Nuclear factor I family members regulate the transcription of surfactant protein-C. J. Biol. Chem. 272:32759-32766.
3. Bachurski, C. J., G. H. Yang, T. A. Currier, R. M. Gronostajski, and D. Hong. 2003. Nuclear factor I/thyroid transcription factor 1 interactions modulate surfactant protein C transcription. Mol. Cell. Biol. 23:9014-9024.
4. Ben-Arie, N., B. A. Hassan, N. A. Bermingham, D. M. Malicki, D. Armstrong, M. Matzuk, H. J. Bellen, and H. Y. Zoghbi. 2000. Functional conservation of atonal and Math1 in the CNS and PNS. Development 127:1039-1048.[Abstract]
5. Bouwman, P., H. Gollner, H. P. Elsasser, G. Eckhoff, A. Karis, F. Grosveld, S. Philipsen, and G. Suske. 2000. Transcription factor Sp3 is essential for post-natal survival and late tooth development. EMBO J. 19:655-661.[CrossRef][Medline]
6. Chaudhry, A. Z., G. E. Lyons, and R. M. Gronostajski. 1997. Expression patterns of the four nuclear factor I genes during mouse embryogenesis indicate a potential role in development. Dev. Dyn. 208:313-325.[CrossRef][Medline]
7. Chaudhry, A. Z., A. D. Vitullo, and R. M. Gronostajski. 1998. Nuclear factor I (NFI) isoforms differentially activate simple versus complex NFI-responsive promoters. J. Biol. Chem. 273:18538-18546.
8. Chaudhry, A. Z., A. D. Vitullo, and R. M. Gronostajski. 1999. Nuclear factor I-mediated repression of the mouse mammary tumor virus promoter is abrogated by the coactivators p300/CBP and SRC-1. J. Biol. Chem. 274:7072-7081.
9. Cole, T. J., N. M. Solomon, R. Van Driel, J. A. Monk, D. Bird, S. J. Richardson, R. J. Dilley, and S. B. Hooper. 2004. Altered epithelial cell proportions in the fetal lung of glucocorticoid receptor null mice. Am. J. Respir. Cell Mol. Biol. 30:613-619.
10. Costa, R. H., V. V. Kalinichenko, and L. Lim. 2001. Transcription factors in mouse lung development and function. Am. J. Physiol. Lung Cell. Mol. Physiol. 280:L823-L838.
11. das Neves, L., C. Duchala, F. Godinho, M. Haxhiu, C. Colmenares, W. Macklin, C. Campbell, K. Butz, and R. Gronostajski. 1999. Disruption of the murine nuclear factor I-A gene (Nfia) results in perinatal lethality, hydrocephalus and agenesis of the corpus callosum. Proc. Natl. Acad. Sci. USA 96:11946-11951.
12. de Jong, R. N., and P. C. van der Vliet. 1999. Mechanism of DNA replication in eukaryotic cells: cellular host factors stimulating adenovirus DNA replication. Gene 236:1-12.[CrossRef][Medline]
13. Engelkamp, D., P. Rashbass, A. Seawright, and V. van Heyningen. 1999. Role of Pax6 in development of the cerebellar system. Development 126:3585-3596.[Abstract]
14. Forster, E., A. Tielsch, B. Saum, K. H. Weiss, C. Johanssen, D. Graus-Porta, U. Muller, and M. Frotscher. 2002. Reelin, Disabled 1, and beta 1 integrins are required for the formation of the radial glial scaffold in the hippocampus. Proc. Natl. Acad. Sci. USA 99:13178-13183.
15. Galceran, J., E. M. Miyashita-Lin, E. Devaney, J. L. Rubenstein, and R. Grosschedl. 2000. Hippocampus development and generation of dentate gyrus granule cells is regulated by LEF1. Development 127:469-482.[Abstract]
16. Gesemann, M., E. D. Litwack, K. T. Yee, U. Christen, and D. D. O'Leary. 2001. Identification of candidate genes for controlling development of the basilar pons by differential display PCR. Mol. Cell. Neurosci. 18:1-12.[CrossRef][Medline]
17. Geurts, J. M., E. F. Schoenmakers, E. Roijer, A. K. Astrom, G. Stenman, and W. J. van de Ven. 1998. Identification of NFIB as recurrent translocation partner gene of HMGIC in pleomorphic adenomas. Oncogene 16:865-872.[CrossRef][Medline]
18. Glasser, S. W., M. S. Burhans, T. R. Korfhagen, C. L. Na, P. D. Sly, G. F. Ross, M. Ikegami, and J. A. Whitsett. 2001. Altered stability of pulmonary surfactant in SP-C-deficient mice. Proc. Natl. Acad. Sci. USA 98:6366-6371.
19. Greenberg, J. M., F. Y. Thompson, S. K. Brooks, J. M. Shannon, and A. L. Akeson. 2004. Slit and robo expression in the developing mouse lung. Dev. Dyn. 230:350-360.[CrossRef][Medline]
20. Gronostajski, R. M. 1986. Analysis of nuclear factor I binding to DNA using degenerate oligonucleotides. Nucleic Acids Res. 14:9117-9132.
21. Gronostajski, R. M. 2000. Roles of the NFI/CTF gene family in transcription and development. Gene 249:31-45.[CrossRef][Medli